Daniel Joseph OConnell

All filings by Daniel Joseph OConnell on record concern Acumen Pharmaceuticals, Inc., in the capacity of chief executive. Over a trading history stretching from 6 July 2021 to 21 January 2026, the count stands at 12 filings.

Every open-market trade on record is a sale: 6 sales worth €188k. The rest of the record consists of 4 share grants and 1 option exercise. Since January 2026: no purchases and 3 sales on the market.

Most recently, on 23 January 2026, the filings show an open-market sale worth €14k in Acumen Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.